
|Articles|October 1, 2009
Anti-VEGF monotherapy useful option in patients with RAP
Anti-VEGF monotherapy appears to be an effective treatment for retinal angiomatous proliferation, according to results of a small, retrospective chart review. Although the results indicate that in most cases repeated injections would be needed to achieve improvement of stable vision, treatment based on ocular coherence tomography-confirmed presence of fluid could achieve outcomes similar to monthly injections.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Why ST-100 is expanding from dry eye into corneal wound healing
2
ONL Therapeutics completes enrollment in Phase 2 GALAXY trial for geographic atrophy
3
Eichenbaum Acorns: Building the private academic model with Jeffrey S. Heier, MD
4
Water-soluble CBD eye drops lower IOP and dampen corneal sensitivity in glaucoma mouse model
5
















